Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
Daniela Lazăr, Mihaela Flavia Avram, I Romoşan, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 32, pp. 3583-3616
Open Access | Times Cited: 128

Showing 51-75 of 128 citing articles:

miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer
Hailin Ke, Songling Wu, Yueyi Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 4528-4536
Open Access | Times Cited: 10
Tumor vessel normalization and immunotherapy in gastric cancer
Xianzhe Yu, Shan He, Jian Shen, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 10
Nucleobindin‐2/nesfatin‐1 enhances the cell proliferation, migration, invasion and epithelial‐mesenchymal transition in gastric carcinoma
Le Ren, Deming Bao, Liming Wang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 19, pp. 4986-4994
Open Access | Times Cited: 10
Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression
Junying Chen, Zeng Wang, Yuxiong Ding, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 15
Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
Jingwei Liu, Hao Li, Liping Sun, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 15
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
Jingxuan Xu, Jian Wen, Shuangquan Li, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 14
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
Simeng Zhang, Mengzhu Lv, Yu Cheng, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Long noncoding RNA FAM225A promotes the malignant progression of gastric cancer through the miR-326/PADI2 axis
Xiang Ma, Gang Wang, Hao Fan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Relationships among microbiota, gastric cancer, and immunotherapy
Yuzhen Li, Xiaona Huang, Tong De-Sheng, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9
A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer
Zhidong Huang, Kaixin Lou, Hong Liu
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Integrative analysis of immune microenvironment-related CeRNA regulatory axis in gastric cancer
Jie Chen, Jinggui Chen, Bo Sun, et al.
Mathematical Biosciences & Engineering (2020) Vol. 17, Iss. 4, pp. 3953-3971
Open Access | Times Cited: 13
Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics
Li Yang, Jinshen Wang, Tao Zhang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 13
Research progress on tumour‑associated macrophages in gastric cancer (Review)
Zidi Zhou, Zhilong Yang, Jingzhi Wang, et al.
Oncology Reports (2021) Vol. 45, Iss. 4
Open Access | Times Cited: 12
Prognosis stratification and response to treatment in breast cancer based on one-carbon metabolism-related signature
Tongxin Zhang, Jingyu Liu, Meihuan Wang, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Immunotherapy for gastric cancer and liver metastasis: Is it time to bid farewell
Ahmed Dehal
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 8, pp. 2365-2368
Open Access | Times Cited: 1
Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer
Yang Li, Hong‐Chang Wang, Jinshen Wang, et al.
FEBS Open Bio (2020) Vol. 10, Iss. 6, pp. 1149-1161
Open Access | Times Cited: 11
Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures
Ying Tong, Yiwen Yu, Hui Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
Glutamate-cysteine ligase catalytic and its modifier function as novel immunotargets in gastric adenocarcinoma
Dezhuan Da, Zhiang Pan, Lu Zeng, et al.
Asian Journal of Surgery (2022) Vol. 46, Iss. 1, pp. 143-149
Open Access | Times Cited: 7
Evaluation of Immune Infiltration Based on Image Plus Helps Predict the Prognosis of Stage III Gastric Cancer Patients with Significantly Different Outcomes in Northeastern China
Tianyi Fang, Zhidong Wang, Xin Yin, et al.
Disease Markers (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 7
CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages
Jiabin Wang, You-Xin Gao, Yin‐Hua Ye, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 22-37
Open Access | Times Cited: 7
Helicobacter pylori promotes gastric cancer progression by upregulating semaphorin 5A expression via ERK/MMP9 signaling
Guoqing Pan, Xianwen Wang, Yingxia Wang, et al.
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 256-264
Open Access | Times Cited: 9
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models
Kate Crawford, Erin Bontrager, Margaret A. Schwarz, et al.
Cancer Biology & Therapy (2021) Vol. 22, Iss. 10-12, pp. 619-629
Open Access | Times Cited: 9
The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors
Yinxin Wu, Zhuoying Du, Jie Mou, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 20, pp. 2340-2353
Closed Access | Times Cited: 6
C4orf47 is a Novel Prognostic Biomarker and Correlates with Infiltrating Immune Cells in Hepatocellular Carcinoma
Hye-Ran Kim, Choong Won Seo, Sang Jun Han, et al.
Journal of Experimental & Biomedical Sciences/Biomedical Science Letters (2023) Vol. 29, Iss. 1, pp. 11-25
Open Access | Times Cited: 3
Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer
Liang Zheng, Luping Lin, Jintian Song, et al.
Central European Journal of Immunology (2023) Vol. 48, Iss. 1, pp. 14-25
Open Access | Times Cited: 3

Scroll to top